Results 181 to 190 of about 703,096 (358)

The Use of Proton Pump Inhibitors Among Adults in Norway-A Nationwide Drug Utilization Study. [PDF]

Pharmacol Res Perspect
Fossmark R, Molnes S, Sagatun L, Salvesen Ø, Spigset O.   +4 more
europepmc   +1 more source

A novel oral dosage form that reduces food-drug interactions responsible for low drug absorption in the fed state: utilization of enteric coating agents that start to dissolve at higher pH

, 2010
Fumié K. Tanno, Shinji Sakuma, Hiroyasu Kokubo, Shinji Yamashita   +3 more
openalex   +2 more sources

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

Molecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang, Ayesha Alvero, Yi Qin, Mingjin Wang, Alexandra Fox, Yanfeng Li, Michael Millman, Amy Kemper, Gil Mor, Xian Shuang Liu, Michael Chopp, Zheng Gang Zhang, Yi Zhang   +12 more
wiley   +1 more source

Electronic data sources for drug utilization research and healthcare decision-making in Mexico. [PDF]

BMC Health Serv Res
Santa-Ana-Tellez Y, Dreser Mansilla A, Castro Pastrana LI, Salas M, Sánchez Salgado JC, Gómez-Galicia D, Freitas Leal L, Cruz Lopes L.   +7 more
europepmc   +1 more source

Trends in antibiotic utilization associated with the "Do bugs need drugs?" program in British Columbia

, 2009
Elaine Fuertes
openalex   +2 more sources

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

Molecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann, Eduardo García‐Galea, Alice O'Farrell, Zak Kinsella, Maxime Meylan, Florent Petitprez, Ingrid Arijs, Tom Venken, Hari Ps, Adrian Lärkeryd, Ian Miller, Janick Selves, Nadja Meindl‐Beinker, Fiorella Ruiz‐Pace, Elena Élez, Raquel Comas‐Navarro, Frank Lincoln, Dirk Fey, Gift Nyamundanda, Aoife Nolan, Joern Lewin, Raquel Perez‐Lopez, Jonathan Briody, Kathleen Bennett, Walter Kolch, David Matallanas, Alexander Kel, Enrique Arenas, Joaquín Arribas, Bart Ghesquière, Josep Tabernero, Julie Meilleroux, Deborah McNamara, Ray McDermott, Marvin Lim, Mary O'Reilly, Brian Bird, Lisa Stack, Lucia Moloney, Patrick Morris, Keith Egan, Maciej Milewski, Lars Scheuer, Joachim Behringer, Georg Bolz, Ramon Salazar, Cristina Santos, Andrea Ruiz, Orla Casey, Verena Murphy, Matthias Ebert, Livio Trusolino, Diether Lambrechts, Anguraj Sadanandam, Catherine Sautès‐Fridman, Jochen Prehn, Paolo Nuciforo, Jacques Fieschi, Florence Monville, Darran O'Connor, Wolf Fridman, Annette Byrne   +61 more
wiley   +1 more source

Care pathway in patients after myocardial infarction in Denmark - healthcare and drug utilization. [PDF]

Int J Cardiol Heart Vasc
Flege MM, Kleinschmidt T, Hansen S, Jensen KJ, Jensen HK, Christiansen MK, Merland CO, Petersen J.   +7 more
europepmc   +1 more source

Opioid Drug Utilization and Cost Outcomes Associated With the Use of Buprenorphine-Naloxone in Patients With a History of Prescription Opioid Use [PDF]

, 2008
Aman Deep Kaur, Angela L McQueen, Saira Jan   +2 more
openalex   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Drug utilization pattern among type II diabetic patients in Palestine. [PDF]

BMC Health Serv Res
Abualhasan M, Awad M, Sweileh W.
europepmc   +1 more source